What institutional investors actually do with investment bank research
Long-term institutional investors—pension funds, endowments, insurance companies, asset managers—use investment bank research as one input among many, not as a decision-maker. A pension fund managing $50 billion does not buy a stock because an analyst at Goldman Sachs says to. Instead, they use the research to fill gaps in their own analysis, to test their thinking against someone else's, and to understand what the broader market is pricing into a stock.
The research arrives in two forms: published reports that any investor can read, and unpublished conversations with the bank's analysts. The published reports are free marketing—the bank wants the investor to trade through them. The conversations are where the real work happens. An institutional investor's portfolio manager might call an analyst to ask: "Your model assumes 12% revenue growth. What happens to your price target if competition forces that down to 8%?" The analyst's answer shapes whether the fund buys, holds, or sells.
Timing matters. A pension fund does not trade on research the day it lands. They might sit with a report for weeks, cross-check the numbers against their own models, and only then move. By then, the market has usually already priced in what the analyst said. This is why institutional investors often say that published research is "already in the price."
Key Takeaways
- Institutional investors use investment bank research to validate their own analysis and spot blind spots, not to make trading decisions on their own.
- Published reports are marketing tools designed to encourage trading; the real influence happens in private conversations between portfolio managers and analysts.
- A pension fund or endowment typically holds a stock for years, so they care more about whether the analyst's long-term assumptions are sound than about short-term price targets.
- Institutional investors cross-check analyst models against their own data and often disagree with published conclusions before deciding whether to trade.
- Investment banks employ analysts partly to generate trading commissions, so institutional investors treat their research as biased toward optimism and account for that bias in their decisions.
How institutional investors get access to research
Large institutional investors have direct relationships with investment banks. A pension fund with $10 billion in assets will have a dedicated team at multiple banks—JPMorgan, Morgan Stanley, Bank of America, Citigroup—assigned to service their account. These teams send research, host conference calls with company management, and arrange one-on-one meetings between the fund's analysts and the bank's analysts.
Smaller institutional investors—regional asset managers, smaller endowments—get research through their brokerage accounts or through subscriptions to research platforms like FactSet, Morningstar, or Bloomberg Terminal. These platforms aggregate research from multiple banks and make it searchable by company, sector, or analyst name. A $500 million fund might not have a direct relationship with Goldman Sachs, but they can read every report Goldman publishes through Bloomberg.
The bank's incentive is to keep the investor trading. Every time an institutional investor buys or sells a stock, they pay a commission to the bank that executes the trade. A single large trade might generate $50,000 to $500,000 in commission, depending on the stock and the size. The research is the hook. The bank sends a report saying a stock is undervalued, the investor reads it, decides to buy, and executes the trade through that bank. The bank keeps a portion of the commission.
What institutional investors actually look for in research
An institutional investor reading an analyst report is not looking for a recommendation. They are looking for the model. Specifically: What assumptions did the analyst make about revenue growth, margins, capital spending, and discount rates? Are those assumptions reasonable? Do they match what the investor's own team believes?
A pension fund's analyst might read a report on a semiconductor company and see that the analyst assumes the company will capture 15% market share in a new product category within three years. The pension fund's analyst might think that is too optimistic—they believe 10% is more realistic. So they adjust the model, recalculate the valuation, and arrive at a lower price target than the bank published. They then decide whether to buy at the current market price based on their own number, not the bank's.
Institutional investors also look for what the analyst knows that is not yet public. An analyst who covers semiconductor companies might have visited the company's manufacturing facility, spoken to customers, or attended industry conferences. That ground-level intelligence can reveal trends that do not yet show up in financial statements. A pension fund values that context, even if they ultimately disagree with the analyst's conclusion.
They also pay attention to what the analyst is not saying. If an analyst has covered a company for five years and suddenly stops publishing research, that silence can signal that the bank's relationship with the company has deteriorated or that the analyst has lost conviction. Institutional investors notice these shifts.
Why institutional investors distrust published research
Investment banks have a structural conflict of interest. The bank's equity research team publishes reports to drive trading commissions. The bank's investment banking team works with the same companies to arrange mergers, acquisitions, and debt offerings. A bank is unlikely to publish a harsh report on a company that is also a client paying the bank millions in investment banking fees.
Institutional investors know this. Studies have shown that analyst recommendations skew toward "buy" and "hold" and away from "sell." When a bank does publish a "sell" rating, it often comes after the stock has already fallen significantly, meaning the research is confirming what the market already knows rather than predicting it.
Because of this bias, institutional investors treat published research as one data point among many. They might read a report saying a stock is a buy, but then they run their own financial model, talk to the company's competitors, and review the company's recent earnings calls. Only after that work do they decide whether to buy. The research shaped their thinking, but it did not determine their action.
The role of analyst calls and conferences
Investment banks host quarterly earnings calls where company management discusses financial results and takes questions from analysts and investors. These calls are open to anyone, but institutional investors get special access: they can ask questions directly, and they often have private meetings with management before or after the call.
Institutional investors use these calls to test the analyst's thesis. If an analyst published a report saying the company's margins are about to expand, the investor will listen carefully to management's commentary on costs and pricing power. If management sounds uncertain or defensive about margins, the investor might decide the analyst's report is too optimistic.
Investment banks also host investor conferences where company executives present to a room full of institutional investors and analysts. These events are networking opportunities. A pension fund's portfolio manager might have lunch with a company's CFO, ask detailed questions about strategy, and come away with a sense of whether management is credible. That judgment shapes how much weight they give to analyst research on that company.
How institutional investors use research to manage risk
A long-term institutional investor holds a stock for years, sometimes decades. They care less about whether the stock goes up next quarter and more about whether their original thesis is still intact. Research helps them monitor that thesis.
Suppose a pension fund bought a utility stock because they believed the company would steadily raise its dividend for the next 20 years. An analyst publishes research saying new environmental regulations will force the company to spend billions on infrastructure upgrades, which could pressure dividends. The pension fund does not panic and sell when ready. Instead, they use the research as a signal to dig deeper. They might request a meeting with the company's investor relations team, review the regulatory landscape themselves, and decide whether the analyst's concern is real. If it is, they might reduce their position or hold and accept lower dividend growth. If it is not, they ignore the research and hold.
Research also helps institutional investors spot when their thesis has broken down. If an investor bought a stock because they believed the company had a durable competitive advantage, and an analyst publishes research showing that advantage is eroding, that is a red flag worth investigating. The research does not make the decision, but it prompts the investor to reassess.
The economics of research for institutional investors
Large institutional investors pay for research indirectly through trading commissions. When a pension fund executes a trade, they pay a commission to the bank. Part of that commission is allocated to research—the bank's way of charging for the reports and analyst access the fund receives.
This model creates a problem: the bank has an incentive to encourage trading, even if trading is not in the investor's interest. A pension fund that holds stocks for 20 years does not need to trade frequently. But the bank benefits if the fund trades more often. So the bank's research team publishes reports designed to prompt action. They might upgrade a stock from "hold" to "buy," not because the fundamentals have changed, but because they want the investor to trade.
Sophisticated institutional investors understand this incentive and adjust accordingly. They might read research from multiple banks and look for consensus. If five banks all say a stock is a buy, that is more credible than one bank saying it. They might also track which analysts have been right and which have been wrong over time, and weight the research accordingly. An analyst with a track record of accurate calls gets more attention than one with a history of missed predictions.
Frequently Asked Questions
Do institutional investors follow analyst price targets?
Not directly. A pension fund might read that an analyst has a $150 price target on a stock trading at $120, but they do not automatically buy. Instead, they ask: What assumptions underlie that target? Are they reasonable? What would have to change for the target to be wrong? Only after answering those questions do they decide whether to buy.
What happens when an analyst changes their recommendation?
Institutional investors pay attention, but they do not automatically follow. They want to know why the analyst changed their mind. Did the company's fundamentals deteriorate, or did the analyst straightforward recalibrate their model? If the change reflects new information, the investor investigates. If it reflects a shift in the analyst's opinion without new facts, the investor might ignore it.
Can institutional investors get research that retail investors cannot?
Yes. Large institutional investors get private conversations with analysts, access to management meetings, and research that is published only for the bank's largest clients. Retail investors can read published reports, but they do not get the unpublished context and conversations that shape institutional decisions.
How much does investment bank research influence institutional investment decisions?
Research is one input among many. A pension fund's decision to buy a stock depends on their own financial model, their assessment of management quality, their view of industry trends, and their portfolio needs. Research might confirm their thinking or challenge it, but it rarely determines the decision on its own.
Why do institutional investors still use research if they know it is biased?
Because biased information is still information. An analyst's ground-level knowledge of an industry, their conversations with company management, and their detailed financial model are valuable even if the analyst's ultimate recommendation is too optimistic. Institutional investors extract the useful parts and discard the rest.